B Manasa¹*, Dr. V Shanmugam² and P Prakash³

¹M. Pharmacy, Department of Pharmaceutics, Sri Padmavathi School of Pharmacy, Jawaharlal Nehru Technological University, Anantapur, India
²M. Pharm, (Ph.D.) Assistant Professor, Sri Padmavathi School of Pharmacy, Jawaharlal Nehru Technological University, Anantapur, India
³M. Pharm, Assistant Professor, Sri Padmavathi School of Pharmacy, Jawaharlal Nehru Technological University, Anantapur, India

*Corresponding Author: Dattatreya Mukherjee, Intern at First Affiliated Hospital of Jinan University and Research Scholar at International School, Jinan University, P.R China.

Received: July 20, 2020; Published: December 09, 2021

Abstract

Proniosomes are vesicular systems, in which the vesicles are made up of non-ionic based surfactants, cholesterol and other additives. Semisolid liquid crystal gel (proniosomes) prepared by dissolving the surfactant in a minimal amount of an acceptable solvent, namely ethanol and then hydration with least amount of water to form a gel. Itraconazole is a BCS class-II Triazole anti fungal drug having greater first pass metabolism and lesser bioavailability. The Present study was aimed at preparing six formulations of Topical Proniosomal gels with different concentrations of surfactants and cholesterol. All the prepared formulations were evaluated for, % Entrapment efficiency, In-vitro drug release studies, FT-IR studies, Vesicle size analysis Scanning electron microscopy and In vitro anti fungal studies. Among all the formulations IPN6 was found to exhibit optimum results for all the evaluation tests and In vitro drug release was found to be 90.10% at the end of 8th hour. The drug release of all formulations followed Higuchi kinetics on fitting the drug release data to various kinetic models. Thus Proniosomal gels are the promising approach for Itraconazole to overcome the gastrointestinal side effects and to increase the drug bioavailability.

Keywords:  Itraconazole; Proniosomal Gel; Coacervation Phase Separation Method; Non Ionic Surfactants; Soyalecithin; Cholesterol

References

1. Anahita Fathi azarbayjani., et al. “Transdermal Delivery of Haloperidol by Proniosomal Formulations with Non-ionic Surfactants”. Biological and Pharmaceutical Bulletin 8 (2009): 1453-1458.
2. Adnan Azeem., et al. “Feasibility of Proniosomes-Based Transdermal Delivery of Frusemide: Formulation Optimization and PharmacoteXC Xchnical Evaluation”. Pharmaceutical Development and Technology 3 (2008): 155-163.
3. D Nagasamy Venkatesh., et al. “A Superior Drug Delivery System”. International Journal of Pharmaceutical Sciences and Drug Research3 (2014): 178-182.
4. Dr Sanju Nanda., et al. “Formulation, evaluation, and optimization of transdermal gel of ketorolac tromethamine using face centered central composite design”. International Journal of Pharmacy and Pharmaceutical Sciences 4 (2014): 133-139.
5. GV Radha., et al. “A review on proniosomal drug delivery system for targeted drug action”. Journal of Basic and Clinical Pharmacy2 (2013): 42-48.
6. Gagandeep Benipal. “Design, Development and Evaluation of Proniosomal Gel of an Antifungal Drug-Ketoconazole”. International Journal of Pharmaceutical Sciences Review and Research 2 (2015): 265-272.
7. HO Ammara., et al. “Proniosomes as a carrier system for transdermal delivery of tenoxicam”. International Journal of Pharmaceutics 405 (2011): 142 -152.
8. Ibrahim A Alsarra. “Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery”. Journal of Microencapsulation3 (2009): 272-278.
9. Itraconazole-Drug bank (2016).
10. Prabhakar Reddy Veerareddy and Sharan Kumar Reddy Bobbala. “Enhanced oral bioavailability of isradipine via proniosomal systems”. Drug Development and Industrial Pharmacy (2012): 1-9.
11. Reena Thakur., et al. “Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation”. Journal of Drug Targeting6 (2009): 442-449.
12. Shweta Vashist., et al. “Formulation and evaluation of proniosomal gel of diclofenac sodium by using 32 factorial design”. International Journal of Biopharmaceutics 1 (2015): 48-54.
13. Sonam Ajay Singh., et al. “Proniosomes: a recent advancement in vesicular drug delivery system”. World Journal of Pharmaceutical Research 4 (2015): 1671-1689.
14. Srividhya Vardhani CH and Nirosha M. “Formulation and Evaluation of Topical Proniosomal Gel of an Anti-Fungal Drug-Itraconazole”. International Journal of Current Trends in Pharmaceutical Research 6 (2016): 307-313.
15. Thulasi Chowdary G., et al. “In vitro Dynamics of Ibuprofen Incorporated Proniosomal Gel”. Indian Journal of Pharmaceutical Education and Research40 (2013): 59-64.
16. Yasam Venkata Ramesh., et al. “Proniosomes: A Novel Nano Vesicular Transdermal Drug Delivery”. Journal of Pharmaceutical Sciences and Research8 (2013): 153-158.

Citation

Citation: B Manasa., et al. “Formulation and Evaluation of Itraconazole Proniosomal Gel for Topical Drug Delivery". Acta Scientific Pharmaceutical Sciences 6.1 (2022): 18-43.